Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature (Q38474254)
Jump to navigation
Jump to search
scientific article published on 27 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature |
scientific article published on 27 April 2015 |
Statements
1 reference
Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature (English)
1 reference
S Sasse
O Shonukan
27 April 2015
1 reference